Oxandrin dosage

hepatoma / Delayed / Incidence not known
hepatic failure / Delayed / Incidence not known
hepatic necrosis / Delayed / Incidence not known
virilization / Delayed / Incidence not known
clitoromegaly / Delayed / Incidence not known
hyperkalemia / Delayed / Incidence not known
new primary malignancy / Delayed / Incidence not known
prostatic hypertrophy / Delayed / Incidence not known
epididymitis / Delayed / Incidence not known
feminization / Delayed / Incidence not known
teratogenesis / Delayed / Incidence not known
coagulopathy / Delayed / Incidence not known
clotting factor deficiency / Delayed / Incidence not known

Risk of peliosis hepatis, liver cell tumors, blood lipid changes associated with atherosclerosis. Discontinue if cholestatic hepatitis, jaundice, abnormal liver function tests, or hypercalcemia occurs. Cardiovascular disease. COPD. Edematous conditions. Hepatic or renal dysfunction. Monitor hepatic function, serum lipids, Hgb/Hct, and bone age (children) periodically. Monitor for signs of virilization in women; discontinue if mild virilism occurs to prevent irreversible condition. Elderly. Young children. Nursing mothers: not recommended.

Oxandrin dosage

oxandrin dosage

Media:

oxandrin dosageoxandrin dosageoxandrin dosageoxandrin dosageoxandrin dosage

http://buy-steroids.org